Skip to main content
TipRanks
Go Ultimate75% OFF

Eton Pharmaceuticals (ETON) Ratios

603 Followers

Eton Pharmaceuticals Ratios

ETON's free cash flow for Q3 2026 was $35.23M. For the 2026 fiscal year, ETON's free cash flow was decreased by $-13.00K and operating cash flow was $35.24M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.572.061.653.105.18
Quick Ratio1.171.291.603.015.06
Cash Ratio0.670.751.322.523.16
Solvency Ratio-0.01-0.05-0.00-0.61-0.15
Operating Cash Flow Ratio0.270.050.420.75-1.04
Short-Term Operating Cash Flow Coverage1.2012.751.274.67-3.33
Net Current Asset Value$ -5.38M$ -10.67M$ 10.58M$ 8.05M$ 13.77M
Leverage Ratios
Debt-to-Assets Ratio0.340.390.170.260.24
Debt-to-Equity Ratio1.191.230.350.500.38
Debt-to-Capital Ratio0.540.550.260.330.28
Long-Term Debt-to-Capital Ratio0.450.550.000.290.23
Financial Leverage Ratio3.523.122.051.911.56
Debt Service Coverage Ratio0.31-0.32-0.10-6.28-0.73
Interest Coverage Ratio0.02-1.300.000.000.00
Debt to Market Cap0.070.090.050.090.06
Interest Debt Per Share1.331.240.210.260.27
Net Debt to EBITDA1.19-22.9254.931.517.46
Profitability Margins
Gross Profit Margin53.46%60.01%66.56%67.38%87.99%
EBIT Margin0.28%-4.62%-3.77%-38.87%-6.85%
EBITDA Margin5.34%-1.68%-0.92%-30.52%-4.73%
Operating Profit Margin0.09%-6.66%-3.77%-38.87%-6.85%
Pretax Profit Margin-5.70%-9.76%-2.18%-42.45%-8.95%
Net Profit Margin-5.75%-9.80%-2.96%-42.45%-8.95%
Continuous Operations Profit Margin-5.75%-9.80%-2.96%-42.45%-8.95%
Net Income Per EBT100.94%100.39%135.85%100.00%100.00%
EBT Per EBIT-6330.56%146.63%57.80%109.21%130.77%
Return on Assets (ROA)-4.99%-5.02%-2.95%-36.04%-7.12%
Return on Equity (ROE)-17.59%-15.65%-6.05%-68.98%-11.09%
Return on Capital Employed (ROCE)0.13%-4.62%-7.69%-44.48%-6.53%
Return on Invested Capital (ROIC)0.12%-4.62%-5.71%-42.14%-6.15%
Return on Tangible Assets-7.51%-9.27%-3.47%-44.49%-8.20%
Earnings Yield-1.01%-1.11%-0.83%-12.72%-1.81%
Efficiency Ratios
Receivables Turnover6.807.289.2811.473.99
Payables Turnover3.393.745.733.931.48
Inventory Turnover2.411.0211.6112.454.77
Fixed Asset Turnover125.71186.66210.9581.7399.69
Asset Turnover0.870.511.000.850.79
Working Capital Turnover Ratio3.702.462.621.301.09
Cash Conversion Cycle97.26309.057.02-31.84-78.86
Days of Sales Outstanding53.6750.1639.3531.8191.47
Days of Inventory Outstanding151.25356.3931.4329.3276.53
Days of Payables Outstanding107.6797.5063.7592.97246.86
Operating Cycle204.92406.5570.7761.13168.00
Cash Flow Ratios
Operating Cash Flow Per Share0.390.040.270.19-0.19
Free Cash Flow Per Share0.380.040.240.08-0.32
Dividend Paid and CapEx Coverage Ratio31.6037.278.791.73-1.45
Capital Expenditure Coverage Ratio31.6037.278.791.73-1.45
Operating Cash Flow Coverage Ratio0.340.031.260.74-0.71
Operating Cash Flow to Sales Ratio0.130.020.220.23-0.22
Free Cash Flow Yield2.24%0.27%5.38%2.87%-7.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-99.47-88.80-120.01-7.86-55.31
Price-to-Sales (P/S) Ratio5.698.843.553.344.95
Price-to-Book (P/B) Ratio17.4014.127.265.426.13
Price-to-Free Cash Flow (P/FCF) Ratio44.65365.7718.6034.88-13.55
Price-to-Operating Cash Flow Ratio43.24355.9616.4814.71-22.91
Price-to-Earnings Growth (PEG) Ratio-7.46-0.291.34-0.020.59
Enterprise Value Multiple107.83-547.91-331.06-9.42-97.22
Enterprise Value460.09M359.98M96.34M61.13M100.43M
EV to EBITDA107.83-547.91-331.06-9.42-97.22
EV to Sales5.759.233.042.884.60
EV to Free Cash Flow45.15381.7415.9530.07-12.58
EV to Operating Cash Flow43.72371.5014.1412.68-21.27
Tangible Book Value Per Share-0.18-0.400.420.330.56
Shareholders’ Equity Per Share0.970.940.600.520.70
Tax and Other Ratios
Effective Tax Rate-0.01-0.00-0.360.000.00
Revenue Per Share2.971.511.230.850.87
Net Income Per Share-0.17-0.15-0.04-0.36-0.08
Tax Burden1.011.001.361.001.00
Interest Burden-20.442.110.581.091.31
Research & Development to Revenue0.100.080.100.190.29
SG&A to Revenue0.450.580.600.870.66
Stock-Based Compensation to Revenue0.070.080.100.200.15
Income Quality-2.29-0.25-7.28-0.532.41

Currency in USD